Inpatient buprenorphine induction means starting buprenorphine for opioid use disorder (OUD) in a supervised setting, where clinicians can watch your withdrawal symptoms, adjust each dose and respond right away if something goes wrong. It is used in hospitals and in residential detox programs. The method is either a standard start, timed to moderate withdrawal, or a low-dose start that begins while you are still taking a full opioid. This guide explains both, what staff monitor, and how to keep the medication going after you leave.
TL;DR
- Standard induction waits until you are in early-to-moderate withdrawal (a COWS score of roughly 8 to 12 or higher) so buprenorphine does not trigger precipitated withdrawal.
- Low-dose induction (sometimes called microdosing) starts with tiny doses, such as 0.25 to 0.5 mg, and builds over about 3 to 7 days without requiring you to be in withdrawal first.
- A supervised setting lets staff track symptoms dose by dose, treat discomfort and slow or pause the process if symptoms jump.
- The induction is only the first step: a bridge prescription and a booked first outpatient appointment are what keep treatment going.
- Clinicians no longer need a DATA waiver to prescribe buprenorphine, so continuing care is easier to arrange than it used to be.
Table of Contents
- What inpatient buprenorphine induction is
- How clinicians decide when to give the first dose
- Standard induction versus low-dose induction
- Precipitated withdrawal: what it is and what staff do
- What monitoring looks like during an inpatient start
- Why the setting matters when you also have a mental health condition
- The perspective from our team
- Getting care started at Connected Recovery
- What happens after induction
- How to choose an inpatient induction setting
- Frequently asked questions
- Sources
What inpatient buprenorphine induction is
Buprenorphine is a partial opioid agonist. It attaches to the same receptors as heroin, fentanyl, oxycodone and other opioids, but activates them less strongly, which eases withdrawal and cravings without the same high or breathing risk. "Induction" is the process of getting from your current opioid use to a stable daily buprenorphine dose.
Doing this inpatient means you are in a monitored bed, not managing it alone at home. Federal research bodies describe hospitalization as a reachable moment to start and coordinate OUD treatment, and hospital medicine guidance notes that offering treatment during a stay can improve linkage to outpatient care and reduce self-directed discharges.
An inpatient start is most useful when:
- You use fentanyl or other potent opioids and fear a bad first dose.
- You have tried to start buprenorphine at home and had precipitated withdrawal or could not tolerate the wait.
- You also have a medical condition or a mental health condition that benefits from close observation.
- You are detoxing from more than one substance, such as opioids plus alcohol or benzodiazepines, which carry their own risks.
- Your home situation makes a safe start difficult.
How clinicians decide when to give the first dose
The COWS score
The Clinical Opiate Withdrawal Scale (COWS) is an 11-item checklist that staff complete by observing and asking you about pulse, sweating, restlessness, pupil size, aches, runny nose, stomach upset, tremor, yawning, anxiety and gooseflesh. It turns what you feel into a number.
For a standard induction, you are generally expected to abstain from opioids until you show moderate withdrawal, with a COWS score often cited as 8 to 12 or higher. That threshold exists because buprenorphine binds receptors so tightly that it can push other opioids off them. If those receptors are still full of fentanyl or heroin, the sudden swap can make you much sicker, not better.
For low-dose protocols, the same guidance says COWS is not required as a gate, because these methods do not need a pre-existing withdrawal state.
Why the wait feels long, especially with fentanyl
Fentanyl is stored in body fat and can linger, so withdrawal onset can be unpredictable. Many people describe waiting in discomfort and then still reacting badly to the first dose. Our guides on the fentanyl withdrawal timeline and COWS and the Suboxone induction checklist go through what the first days typically look like. For a broader view of how long opioid withdrawal runs, see our opioid detox timeline.
Standard induction versus low-dose induction
| Standard induction | Low-dose (microdosing) induction | |
|---|---|---|
| Opioid use before first dose | Stopped until moderate withdrawal appears | Often continues full agonist during the start |
| COWS gate | Typically about 8 to 12 or higher | Not required |
| First doses | Larger test dose, then repeated doses | Very small doses, for example 0.25 to 0.5 mg |
| Typical length | Hours to a day or two to reach a stable dose | Roughly 3 to 7 days to build up |
| Main risk | Precipitated withdrawal if started too early | Slower process; needs a monitored plan |
| Best suited to | People already in withdrawal, short stays | People on fentanyl or long-acting opioids, prior bad starts, or who cannot tolerate withdrawal |
The hospital medicine guidance describes standard induction as requiring a period of abstinence and observable moderate withdrawal, and low-dose induction as the scheduled introduction of small amounts while full agonists continue, which limits both withdrawal and the risk of precipitation. An academic guide on expanding buprenorphine use reports that low-dose protocols commonly begin at 0.25 to 0.5 mg and increase over 3 to 7 days. The same source frames this as a real shift away from the older detox-first model toward an approach that does not require you to go through withdrawal first.
What the early evidence says about low-dose starts
The evidence base is still growing and mostly consists of small studies. In a 33-patient case series of low-dose IV buprenorphine inductions, mean COWS scores fell from 2.6 on day 0 to 1.6 on day 5, and stayed stable or decreased for most patients. That is encouraging for comfort, but 33 patients is not a trial, and results in your situation depend on the opioid you use, your health and the protocol your clinicians choose.
Precipitated withdrawal: what it is and what staff do
Precipitated withdrawal happens when buprenorphine displaces full agonists from your receptors and your symptoms get abruptly worse instead of better. It tends to show up within the first hour or so after a dose and can feel like a sudden, intense flu with vomiting, sweating, anxiety and aching.
According to the hospital medicine implementation guide, clinicians recognize it by a sudden rise in COWS score (for example, 5 points or more) and manage it by:
- Treating the acute symptoms.
- Slowing or pausing the titration.
- Trying again once you are stable.
That last point is the practical argument for doing this under supervision. At home, a bad first dose often ends the attempt and the person goes back to using. With staff present, the same event becomes a manageable setback. Comfort medications for nausea, diarrhea, anxiety, muscle aches and sleep are part of this; our guide to comfort medications for withdrawal explains what they are for.
What monitoring looks like during an inpatient start
Protocols differ by facility, but the principles are consistent: assess before each dose, reassess after, and do not rush. As one reference point from emergency care, a Veterans Affairs educational document on buprenorphine/naloxone advises re-evaluating patients one hour after doses and observing them for an hour after the final dose before discharge. A multi-day inpatient or residential stay allows far more observation than that.
In practice, monitoring typically covers:
- Symptom scoring: repeated COWS checks, usually before and after dosing.
- Vital signs: pulse, blood pressure, temperature and breathing, especially if you have been using sedatives or alcohol.
- Dose adjustment: raising, holding or pausing based on how you respond.
- Comfort care: medications and nursing support for symptoms that buprenorphine alone does not cover.
- Lab work: clinicians often use laboratory drug screening to confirm what substances are in your system and to follow your progress over time.
- Mental health observation: mood, anxiety and sleep changes are common in early recovery and can mask or mimic withdrawal.
Why the setting matters when you also have a mental health condition
Many people with OUD also live with depression, anxiety, trauma or another condition. Withdrawal can make each of these louder, and untreated symptoms are one of the main reasons people leave care early. A setting that treats both at once can adjust medication, therapy and sleep support together. Our dual diagnosis program is built around that integrated approach.
The perspective from our team
We run a small, 12-bed residential facility in Van Nuys, and size shapes how we think about induction. In a large unit, the person starting medication is one of many names on a board. In ours, the clinical team knows each person well enough to notice that a restless night, a skipped meal or a flash of panic is changing how the day should go. With 24/7 medical supervision, we can slow a start down, pause it or adjust comfort care without worrying that the person will slip through the cracks.
We also do not treat induction as the finish line. The medication matters, but what keeps people on it is a plan: who prescribes next, where they fill it, how they will manage cravings, and what happens with housing, work and family. That is why we build discharge and aftercare planning into treatment from the beginning, not in the last 48 hours. And because substance use and mental health so often travel together, we treat them together.
If you are weighing options, ask every program the same questions: Who is awake overnight? What happens if the first dose goes badly? Who writes the bridge prescription? A good program answers plainly.
— Jim
Getting care started at Connected Recovery
Our medical detox and medication-assisted treatment programs are designed for adults who want a supervised, discreet start, with continuing support through residential treatment and aftercare. We do not publish a price list; our admissions team can walk you through coverage and private-pay options.
If you or someone in your family is struggling with opioids, you can learn more about our opioid addiction treatment in Van Nuys or contact us through our site to ask about admission.
What happens after induction
Finishing induction does not mean you are done. The hospital medicine guidance describes stabilizing patients on a total daily dose, then providing a bridge prescription so medication continues until the first outpatient appointment, ideally scheduled shortly after discharge.
Lock in the follow-up before you leave
A gap of even a few days between the last inpatient dose and the first outpatient visit is where many people lose the thread. Before discharge, you should have:
- A bridge prescription in hand, and a pharmacy confirmed to stock it.
- A date, time and location for the first outpatient appointment.
- A named prescriber who will take over maintenance.
- A plan for cravings and for what to do if you slip.
- A list of mutual-help meetings, therapy or other supports.
Our guide to discharge planning after rehab and our aftercare planning page cover how we approach this, and telehealth aftercare can help when getting to appointments is hard. SAMHSA has also published flexibilities for telehealth in buprenorphine initiation for opioid treatment programs in certain clinical and emergency contexts, so ask your provider what is currently allowed.
Prescribers and long-acting options
As of December 29, 2022, clinicians no longer need a DATA waiver to prescribe buprenorphine for OUD, which widens the pool of doctors who can continue your treatment. Long-acting injectable buprenorphine is an emerging option for discharge plans, particularly for people with complex medical needs. A seven-person case series found that low-dose transitions to injectable buprenorphine were feasible for hospitalized patients with serious infections, including some who needed surgery. That is early evidence, and whether it fits you is a conversation with your prescriber.
Buprenorphine and other medications
Buprenorphine is not the only medication for OUD. SAMHSA's TIP 63 reports that in studies comparing the two, patients started on buprenorphine during inpatient induction had significantly lower relapse rates at 24 weeks than those assigned to extended-release naltrexone. Naltrexone still suits some people, and we cover when and how in our naltrexone after detox checklist. For relapse risk after treatment, see our relapse prevention program.
How to choose an inpatient induction setting
Use these criteria when you compare hospitals, detox facilities and residential programs:
- Medical coverage: Is a clinician available around the clock, including nights and weekends?
- Protocol flexibility: Can the team offer both standard and low-dose starts, and explain why they would choose one for you?
- Withdrawal comfort: What is used for nausea, sleep, anxiety and pain?
- Co-occurring conditions: Is mental health care part of the program, or a separate referral?
- Continuity: Who prescribes after discharge, and is a bridge prescription standard?
- Privacy: How are admissions and records handled?
- Size and attention: How many other people is each nurse and clinician responsible for?
Frequently asked questions
What is the COWS score required for buprenorphine induction?
For a standard induction, clinicians generally wait for a COWS score of about 8 to 12 or higher, which indicates early-to-moderate withdrawal. Starting before then raises the risk of precipitated withdrawal. Low-dose protocols do not require that threshold, because they begin with very small doses while you are still on a full opioid.
How long does precipitated withdrawal last?
Duration varies with the opioid involved, the dose and your health, and we cannot give a reliable number. Clinicians manage it by treating symptoms, slowing or pausing dosing and trying again when you are stable. If you are in precipitated withdrawal, tell the nearest clinician at once, and call 911 if you have trouble breathing or chest pain.
Do I have to be in withdrawal before starting buprenorphine?
With a standard start, yes, moderate withdrawal is the usual requirement. With a low-dose start, no: you take tiny, scheduled doses while continuing your current opioid, and build up over roughly 3 to 7 days. Which method is right depends on your opioid, your history and the program's protocol.
Can I start buprenorphine at home instead?
Many people do, and it can work well with good guidance. An inpatient setting adds continuous observation and quick help if symptoms spike, which matters most if you use fentanyl, have had a bad start before, or have other medical or mental health conditions.
What happens when I leave?
You should leave with a stable daily dose, a bridge prescription and a scheduled first outpatient appointment. Ask for all three in writing before discharge, along with the name of your ongoing prescriber.
Sources
- Medication Treatment for Opioid Use Disorder in the Inpatient Setting (NIDA)
- OUD Implementation Guide (Society of Hospital Medicine)
- A Guide to Expanding the Use of Buprenorphine Beyond Traditional Settings (PMC)
- Low dose IV buprenorphine inductions case series (PMC)
- Inpatient Low Dose Transitions from Full Agonist Opioids to Long-Acting Injectable Buprenorphine (PMC)
- Emergency Department and Buprenorphine/Naloxone Treatment (VA)
- TIP 63: Medications for Opioid Use Disorder (SAMHSA)
- FAQs: Provision of methadone and buprenorphine for OUD (SAMHSA)
- Drug screening laboratory diagnostics